nifedipine has been researched along with Cochlear Hearing Loss in 1 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the treatment of patients with sudden deafness, we found no significant difference between an oral calcium antagonist (nifedipine) and intravenous naftidrofuryl given concomitantly with vitamin A, vitamin E, and zinc." | 2.66 | Calcium antagonists in the treatment of sudden deafness. ( Beck, C; Mann, W, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mann, W | 1 |
| Beck, C | 2 |
1 trial available for nifedipine and Cochlear Hearing Loss
| Article | Year |
|---|---|
Calcium antagonists in the treatment of sudden deafness.
Topics: Adult; Female; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Male; Middle Aged; Nafrony | 1986 |